gsi-136
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00719394)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
NAE1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCC(CC)[C@@H](CO)NS(=O)(=O)c1ccc(Cl)s1- Mol. weight
- 311.86 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL480558 ↗
Also known as
- gsi-136
- gsi-136
- gsi-136
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00718731 | Phase 1 | Mar 1, 2008 | Pfizer, Wyeth |
| NCT00719394 | Phase 1 | Mar 1, 2008 | Pfizer, Wyeth |
Showing 2 of 2 trials
Page 1 / 1